Unknown

Dataset Information

0

Increased serum anti-N-methyl-D-aspartate receptor antibody immunofluorescence in psychiatric patients with past catatonia.


ABSTRACT:

Objective

Anti-N-methyl-D-aspartate receptor (NMDAR) antibody was thought to be the cause of anti-NMDAR encephalitis, with manifestations similar to catatonia and schizophrenia. Anti-NMDAR antibody in neuropsychiatric patients who had catatonia before were investigated in a follow-up evaluation. The intensity of antibody immunofluorescence was quantified and compared with healthy controls.

Method

Nineteen patients (eight males and eleven females) agreed to be followed-up. Thirteen had the diagnosis of schizophrenia, two had the diagnosis of major depressive disorder, two had bipolar disorder, one had postpartum depression, and one had herpes simplex encephalitis. No patient had catatonia during the follow-up. Nineteen sex-matched healthy controls were recruited.

Results

Using Mann-Whitney U test, patients had greater intensity of anti-NMDAR antibody immunofluorescence than the healthy controls (121,979 ± 86,526 vs. 47,692 ± 26,102, p = 0.003). No correlation was found between immunofluorescence intensity and catatonia scales or symptom severity scores. Neuropsychiatric patients with past catatonia showed greater anti-NMDAR antibody response than the healthy controls.

Conclusion

NMDAR dysfunction might play a role in the mechanism underlying catatonia. Further studies are needed to confirm this finding.

SUBMITTER: Lin CC 

PROVIDER: S-EPMC5658162 | biostudies-literature | 2017

REPOSITORIES: biostudies-literature

altmetric image

Publications

Increased serum anti-N-methyl-D-aspartate receptor antibody immunofluorescence in psychiatric patients with past catatonia.

Lin Chin-Chuen CC   Hung Yi-Yung YY   Tsai Meng-Chang MC   Huang Tiao-Lai TL  

PloS one 20171026 10


<h4>Objective</h4>Anti-N-methyl-D-aspartate receptor (NMDAR) antibody was thought to be the cause of anti-NMDAR encephalitis, with manifestations similar to catatonia and schizophrenia. Anti-NMDAR antibody in neuropsychiatric patients who had catatonia before were investigated in a follow-up evaluation. The intensity of antibody immunofluorescence was quantified and compared with healthy controls.<h4>Method</h4>Nineteen patients (eight males and eleven females) agreed to be followed-up. Thirteen  ...[more]

Similar Datasets

| S-EPMC7059175 | biostudies-literature
| S-EPMC7322422 | biostudies-literature
| S-EPMC9886530 | biostudies-literature
| S-EPMC7907499 | biostudies-literature
| S-EPMC10684375 | biostudies-literature
| S-EPMC10116423 | biostudies-literature
| S-EPMC6209679 | biostudies-literature
| S-EPMC10166655 | biostudies-literature
| S-EPMC9114484 | biostudies-literature
| S-EPMC6055984 | biostudies-literature